BCL2 genetic variants are associated with acute kidney injury in septic shock

Critical Care Medicine

Volumn 40, Issue 7, 2012, Pages 2116-2123

  Frank, Angela J ^a,b   Sheu, Chau Chyun ^b,c   Zhao, Yang ^b   Chen, Feng ^b   Su, Li ^b   Gong, Michelle N ^d   Bajwa, Ednan ^a   Taylor Thompson, B ^a   Christiani, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; apoptosis; BCL2; genetic susceptibility; sepsis; SERPINA4

Indexed keywords

GENOMIC DNA; HYPERTENSIVE FACTOR; PROTEIN BCL 2; PROTEIN KINASE; SALT INDUCED KINASE FAMILY 3; SERINE PROTEINASE INHIBITOR; SERPIN PEPTIDASE INHIBITOR A4; SERPIN PEPTIDASE INHIBITOR A5; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT;

ACUTE KIDNEY INJURY; AGED; FEMALE; GENES, BCL-2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SERPINS; SHOCK, SEPTIC;

EID: 84862739598     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182514bca     Document Type: Article

References (58)

1. Ostermann M, Chang RW: Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35:1837-1843; quiz 1852 (Pubitemid 47220356)
2. Bagshaw SM, George C, Dinu I, et al: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23:1203-1210 (Pubitemid 351767483)
3. Hoste EA, Clermont G, Kersten A, et al: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10:R73
4. Barrantes F, Tian J, Vazquez R, et al: Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med 2008; 36:1397-1403 (Pubitemid 351620641)
5. Thakar CV, Christianson A, Freyberg R, et al: Incidence and outcomes of acute kidney injury in intensive care units: A Veterans Administration study. Crit Care Med 2009; 37:2552-2558
6. Bagshaw SM, George C, Bellomo R: ANZICS Database Management Committee: Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007; 11:R68
7. Uchino S, Kellum JA, Bellomo R, et al: Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818
8. Bagshaw SM, Uchino S, Bellomo R, et al: Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431-439
9. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committee: Early acute kidney injury and sepsis: A multicentre evaluation. Crit Care 2008; 12:R47
10. Neveu H, Kleinknecht D, Brivet F, et al: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996; 11:293-299 (Pubitemid 26063074)
11. Bagshaw SM, Lapinsky S, Dial S, et al: Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009; 35:871-881
12. Oppert M, Engel C, Brunkhorst FM, et al: German Competence Network Sepsis (Sepnet): Acute renal failure in patients with severe sepsis and septic shock- A significant independent risk factor for mortality: Results from the German Prevalence Study. Nephrol Dial Transplant 2008; 23:904-909 (Pubitemid 351767542)
13. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554 (Pubitemid 36437931)
14. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-1250 (Pubitemid 46642649)
15. Yegenaga I, Hoste E, Van Biesen W, et al: Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: Results of a prospective study. Am J Kidney Dis 2004; 43:817-824 (Pubitemid 38529619)
16. du Cheyron D, Fradin S, Ramakers M, et al: Angiotensin converting enzyme insertion/deletion genetic polymorphism: Its impact on renal function in critically ill patients. Crit Care Med 2008; 36:3178-3183
17. Kolyada AY, Tighiouart H, Perianayagam MC, et al: A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009; 75:1322-1329
18. Perianayagam MC, Liangos O, Kolyada AY, et al: NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18:255-263 (Pubitemid 46053437)
19. Jaber BL, Rao M, Guo D, et al: Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004; 25:212-219 (Pubitemid 38232649)
20. Yang L, Besschetnova TY, Brooks CR, et al: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16:535-543, 1p following 143
21. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
22. Frank AJ, Sheu CC, Chen F, et al: Clinical and genetic determinants of acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 2010; 181:A6818
23. Gong MN, Thompson BT, Williams P, et al: Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion. Crit Care Med 2005; 33:1191-1198 (Pubitemid 40827364)
24. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
25. Keating BJ, Tischfield S, Murray SS, et al: Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE 2008; 3:e3583
26. Purcell S, Neale B, Todd-Brown K, et al: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575 (Pubitemid 47330214)
27. Talmud PJ, Drenos F, Shah S, et al: ASCOT investigatorsNORDIL investigatorsBRIGHT Consortium; Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 2009; 85:628-642
28. Zúñiga J, Buendía-Roldán I, Zhao Y, et al: Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J 2012; 39:604-610
29. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. Available at: http://hydra.usc.edu/gxe. Accessed October 4, 2011
30. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 2011; 80:29-40
31. Lerolle N, Nochy D, Guérot E, et al: Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration. Intensive Care Med 2010; 36:471-478
32. Cantaluppi V, Assenzio B, Pasero D, et al: Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008; 34:1638-1645
33. Guo R, Wang Y, Minto AW, et al: Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 2004; 15:3093-3102 (Pubitemid 39578841)
34. Kelly KJ, Plotkin Z, Dagher PC: Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 2001; 108:1291-1298 (Pubitemid 33107756)
35. Gobé G, Zhang XJ, Willgoss DA, et al: Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11:454-467 (Pubitemid 30115075)
36. Brooks C, Wei Q, Cho SG, et al: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009; 119:1275-1285
37. Chao J, Miao RQ, Chen V, et al: Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biol Chem 2001; 382:15-21
38. Yin H, Gao L, Shen B, et al: Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension 2010; 56:260-267
39. Chen LM, Chao L, Chao J: Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock. Life Sci 1997; 60:1431-1435 (Pubitemid 27461299)
40. Chao J, Yin H, Yao YY, et al: Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Hum Gene Ther 2006; 17:1201-1213 (Pubitemid 44975137)
41. Shen B, Gao L, Hsu YT, et al: Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol 2010; 299:H1419-H1427
42. Hsieh JL, Shen PC, Shiau AL, et al: Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum Gene Ther 2009; 20:147-158
43. Shen B, Hagiwara M, Yao YY, et al: Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension 2008; 51:1358-1365 (Pubitemid 351555950)
44. Jenkins AJ, McBride JD, Januszewski AS, et al: Increased serum kallistatin levels in type 1 diabetes patients with vascular complications. J Angiogenes Res 2010; 2:19
45. Radtke KP, Fernández JA, Greengard JS, et al: Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 1994; 94:2117-2124 (Pubitemid 24348253)
46. Wakita T, Hayashi T, Nishioka J, et al: Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 2004; 108:516-523 (Pubitemid 38036651)
47. Couch FJ, Wang X, Bamlet WR, et al: Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. Cancer Epidemiol Biomarkers Prev 2010; 19:251-257
48. Druml W, Metnitz B, Schaden E, et al: Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med 2010; 36:1221-1228
49. Paolini JB, Mancini J, Genestal M, et al: Predictive value of abdominal obesity vs. body mass index for determining risk of intensive care unit mortality. Crit Care Med 2010; 38:1308-1314
50. Kheterpal S, Tremper KK, Englesbe MJ, et al: Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007; 107:892-902 (Pubitemid 350175671)
51. Volakli E, Spies C, Michalopoulos A, et al: Infections of respiratory or abdominal origin in ICU patients: What are the differences? Crit Care 2010; 14:R32
52. Chertow GM, Burdick E, Honour M, et al: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16:3365-3370 (Pubitemid 46179340)
53. Bellomo R, Ronco C, Kellum JA, et al: Acute Dialysis Quality Initiative workgroup: Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
54. Joannidis M, Metnitz B, Bauer P, et al: Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009; 35:1692-1702
55. Lopes JA, Fernandes P, Jorge S, et al: Acute kidney injury in intensive care unit patients: A comparison between the RIFLE and the Acute Kidney Injury Network classifications. Crit Care 2008; 12:R110
56. Bagshaw SM, George C, Bellomo R: ANZICS Database Management Committe: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23:1569-1574 (Pubitemid 351767782)
57. Satagopan JM, Elston RC: Optimal two-stage genotyping in population-based association studies. Genet Epidemiol 2003; 25:149-157 (Pubitemid 37064870)
58. Wang H, Thomas DC, Pe'er I, et al: Optimal two-stage genotyping designs for genome-wide association scans. Genet Epidemiol 2006; 30:356-368